NEW HAVEN, Conn., June 20, 2025 /PRNewswire/ -- Yale School of Medicine (YSM) announces the launch of the Yale Biomedical Imaging Institute, a cross-disciplinary hub that...
Two cutting-edge platforms at CAMH and Western University aim to accelerate AI-driven brain research and global data sharing
TORONTO, June 20, 2025 /CNW/ - Brain Canada...
Equity Insider News Commentary
Issued on behalf of Avant Technologies Inc.
VANCOUVER, BC, June 20, 2025 /CNW/ -- Equity Insider News Commentary – Amid the wave of new...
Data Add to Growing Body of Evidence Demonstrating Functional and Quality of Life Improvements in Patients Treated with INGREZZA for Tardive Dyskinesia Findings Presented at...
INRS Professor receives $1.2M to advance glioblastoma research
LAVAL, QC, June 20, 2025 /CNW/ - Professor Maya Saleh, a world-renowned expert in immuno-oncology at the Institut national...
GUANGZHOU, China, June 20, 2025 /PRNewswire/ -- With the maturation of AI technology, its application in the FMCG sector holds enormous potential. Building private AI...
"Q-Smart" assistant will provide restaurant managers with broad-based support for day-to-day restaurant operations, allowing them to enhance their focus on delivering excellent customer service
SHANGHAI,...
QUEBEC CITY, June 19, 2025 /PRNewswire/ - Zilia, a Canadian health technology company, is proud to announce that its flagship product, the Zilia Ocular™,...
First FDA-cleared smart ring for multi-night sleep testing and 24/7 biometrics — to catch disease early—years before standard care.
AUSTIN, Texas, June 19, 2025 /PRNewswire/...
The proposition that skill alone can outperform the market is contradicted by substantial empirical data. The research unequivocally suggests that success in surpassing market...
LONDON, June 19, 2025 (GLOBE NEWSWIRE) -- Symbiotic.blue, the UK’s newest Techbio company has launched to innovate a next-generation artificial intelligence-driven drug discovery (AIDD) platform by combining the power of generative AI with brain-inspired methodologies. Symbiotic.blue aims to create smarter, multi-targeted therapeutics to tackle complex diseases.
CAMBRIDGE, Mass., June 18, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer,...